Globus Medical, Inc. Provides Sales Results for the Fourth Quarter and Full Year Ending December 31, 2023; Provides Earnings Guidance for the Full Year Fiscal 2024
January 10, 2024 at 04:35 pm EST
Share
Globus Medical, Inc. provided sales results for the fourth quarter and full year ending December 31, 2023. The company anticipated fourth quarter 2023 sales of approximately $615.5 million, an increase of 124.2% over the fourth quarter 2022 on an as-reported basis.
Full year 2023 sales are expected to be approximately $1.567 billion, an increase of 53.2% over the prior year on an as-reported basis.
The Company established its full year 2024 revenue guidance range of $2.450 billion to $2.475 billion.
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Globus Medical, Inc. Provides Sales Results for the Fourth Quarter and Full Year Ending December 31, 2023; Provides Earnings Guidance for the Full Year Fiscal 2024
GLOBUS MEDICAL, INC. 
